p450 - publications

Predict more p450 - ligand interactions now!



A search for new CYP3A4 variants as determinants of tacrolimus dose requirements in renal-transplanted patients.


Pharmacogenet Genomics. 2013 Jun 14;


Authors: Tavira B, Coto E, Diaz-Corte C, Alvarez V, López-Larrea C, Ortega F


Abstract

The CYP3A5*3 and CYP3A4*1B alleles have been related with tacrolimus (Tac) dose requirements. The rare CYP3A4*22 variant has also been associated with a significantly lower Tac dose. We genotyped the three single-nucleotide polymorphisms in 206 kidney-transplanted patients who received Tac as the primary immunosuppressor. CYP3A5*1 and CYP3A4*1B allele carriers received a significantly higher Tac dose (P<0.01) compared with wild-type homozygotes. We did not find significant differences between the CYP3A4*22 genotypes, either nominally or according to the CYP3A5 genotype (expressers vs. nonexpressers). Sequencing of CYP3A4 coding exons in a total of 15 patients revealed only one nonreported missense change (p.P227>T) in one patient. We concluded that CYP3A5*3 and CYP3A4*1B were the main determinants of the Tac dose-adjusted blood concentration in our cohort of renal-transplanted patients.

PMID: 23778326 [PubMed - as supplied by publisher]